Peter A. Thompson - 24 Jun 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director, 10%+ Owner
Signature
/s/ John R. Moore Attorney-in-Fact for Peter Thompson M.D.
Issuer symbol
EWTX
Transactions as of
24 Jun 2022
Transactions value $
$0
Form type
4
Filing time
28 Jun 2022, 19:17:17 UTC
Previous filing
21 Jun 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +42.1K $0.00 42.1K 24 Jun 2022 Common Stock 42.1K $8.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders.